TPCW
CVS icon

TD Private Client Wealth’s CVS Health CVS Stock Holding History

TD Private Client Wealth’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5M Buy
111,151
+3,945
+4% +$352K 0.21% 71
2026
Q1 		$7.7M Sell
107,206
-4,133
-4% -$318K 0.16% 88
2025
Q4 		$8.84M Sell
111,339
-5,390
-5% -$425K 0.19% 77
2025
Q3 		$8.8M Buy
116,729
+17,055
+17% +$1.17M 0.2% 76
2025
Q2 		$6.88M Buy
99,674
+20,760
+26% +$1.36M 0.17% 88
2025
Q1 		$5.35M Buy
78,914
+47,649
+152% +$2.85M 0.15% 103
2024
Q4 		$1.4M Sell
31,265
-15,673
-33% -$879K 0.04% 293
2024
Q3 		$2.95M Buy
46,938
+10,465
+29% +$611K 0.08% 181
2024
Q2 		$2.15M Buy
36,473
+10,847
+42% +$679K 0.07% 221
2024
Q1 		$2.04M Buy
25,626
+5,064
+25% +$387K 0.07% 233
2023
Q4 		$1.62M Sell
20,562
-4,055
-16% -$289K 0.06% 254
2023
Q3 		$1.72M Sell
24,617
-21,190
-46% -$1.5M 0.07% 231
2023
Q2 		$3.17M Buy
45,807
+5,935
+15% +$422K 0.14% 154
2023
Q1 		$2.96M Buy
39,872
+114
+0.3% +$9.56K 0.13% 158
2022
Q4 		$3.71M Buy
39,758
+13,300
+50% +$1.28M 0.18% 125
2022
Q3 		$2.52M Sell
26,458
-2,999
-10% -$297K 0.13% 165
2022
Q2 		$2.73M Buy
29,457
+555
+2% +$54.2K 0.13% 164
2022
Q1 		$2.93M Sell
28,902
-7,098
-20% -$746K 0.12% 174
2021
Q4 		$3.72M Buy
36,000
+5,023
+16% +$464K 0.15% 150
2021
Q3 		$2.63M Sell
30,977
-256
-0.8% -$21.4K 0.11% 185
2021
Q2 		$2.61M Sell
31,233
-12,206
-28% -$1,000K 0.11% 191
2021
Q1 		$3.27M Buy
43,439
+2,742
+7% +$200K 0.15% 155
2020
Q4 		$2.78M Buy
40,697
+16,559
+69% +$1.08M 0.14% 156
2020
Q3 		$1.41M Sell
24,138
-3,878
-14% -$241K 0.08% 242
2020
Q2 		$1.82M Buy
28,016
+7,729
+38% +$487K 0.11% 197
2020
Q1 		$1.2M Sell
20,287
-10,090
-33% -$674K 0.09% 200
2019
Q4 		$2.26M Buy
+30,377
New +$2.13M 0.14% 162

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

TD Private Client Wealth's CVS Position: Q2 2026 in Review

TD Private Client Wealth increased its CVS Health (CVS) stake by 3.7% in Q2 2026, buying an estimated $352K and bringing the position to 111,151 shares worth $11.5M. The position accounts for 0.21% of the portfolio, ranked #71.

TD Private Client Wealth first reported a position in CVS in Q4 2019 and has held it in 27 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • TD Private Client Wealth held 111,151 shares of CVS Health worth $11.5M as of Q2 2026.
  • TD Private Client Wealth bought 3,945 CVS Health shares in Q2 2026, an estimated $352K.
  • CVS Health made up 0.21% of TD Private Client Wealth's portfolio in Q2 2026, its #71 holding.
  • TD Private Client Wealth first reported a position in CVS Health in Q4 2019 and has held it in 27 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.